搜尋結果
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
Forbes· 16 小時前Data from Lilly’s clinical trial found donanemab, given by intravenous infusion once a month, ...
Lagarde Says ECB Cut Doesn’t Put Rate on ‘Linear Declining Path’
Bloomberg· 5 小時前The European Central Bank must stay cautious, and last week’s cut in borrowing costs won’t necessarily be followed by further ...
A Fine Month For Income Investors
Forbes· 6 日前Declining interest rates gave income investors strong returns in May. Dividend growth stocks didn’t match ...
Yankees’ $31 Million Duo Offers Clear Focus For Trade Deadline
Forbes· 16 小時前Surging to an MLB-leading 46 wins, the New York Yankees have placed themselves firmly into ...
Here's how every social media company is adopting subscriptions
TechCrunch· 15 小時前For the longest time, social media companies have relied on the fact that their service is “free” to use. All these companies ...
Eminem Narrowly Misses Out On Another No. 1 Smash
Forbes· 16 小時前Eminem’s new era has officially started, as the rapper’s latest single has begun arriving on ...
ECB could wait several meetings between rate cuts, Lagarde says
Reuters· 5 小時前The ECB cut rates from a record high last week but held off committing to any more policy ...
French banks, highway stocks plunge as Macron calls snap elections
Reuters· 8 小時前Shares in French banks, tollroad operators and energy firms fell sharply on Monday, after ...
US stocks finish lower after choppy session - RTHK
RTHK· 2 日前Wall Street stocks ended slightly lower on Friday in choppy trading after ...
What to expect from the housing market in the second half of 2024, according to real estate experts
CNBC· 6 小時前"Mostly, we think the housing market is going to improve over the next half of the ...